DK1007530T3 - 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf - Google Patents

6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf

Info

Publication number
DK1007530T3
DK1007530T3 DK97924605T DK97924605T DK1007530T3 DK 1007530 T3 DK1007530 T3 DK 1007530T3 DK 97924605 T DK97924605 T DK 97924605T DK 97924605 T DK97924605 T DK 97924605T DK 1007530 T3 DK1007530 T3 DK 1007530T3
Authority
DK
Denmark
Prior art keywords
compounds
preparation
substituted erythromycin
erythromycin compounds
substituted
Prior art date
Application number
DK97924605T
Other languages
Danish (da)
English (en)
Inventor
Richard F Clark
Zhenkun Ma
Daniel T Chu
Yat Sun Or
George Griesgraber
Leping Li
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/841,038 external-priority patent/US6075011A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1007530T3 publication Critical patent/DK1007530T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK97924605T 1996-05-07 1997-05-06 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf DK1007530T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64647796A 1996-05-07 1996-05-07
US08/841,038 US6075011A (en) 1996-05-07 1997-04-29 6-O-substituted erythromycin compounds and method for making same

Publications (1)

Publication Number Publication Date
DK1007530T3 true DK1007530T3 (da) 2006-04-03

Family

ID=27094941

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97924605T DK1007530T3 (da) 1996-05-07 1997-05-06 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf

Country Status (12)

Country Link
EP (1) EP1007530B1 (de)
AT (1) ATE310010T1 (de)
AU (1) AU726075B2 (de)
BR (1) BR9708929A (de)
CA (1) CA2253330C (de)
CZ (1) CZ351898A3 (de)
DE (1) DE69734678T2 (de)
DK (1) DK1007530T3 (de)
ES (1) ES2252784T3 (de)
IL (1) IL126625A0 (de)
NZ (1) NZ332320A (de)
WO (1) WO1997042206A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000198795A (ja) * 1996-10-31 2000-07-18 Taisho Pharmaceut Co Ltd エリスロマイシンａ誘導体
AU4472797A (en) * 1996-10-31 1998-05-22 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
EP0895999A1 (de) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4"-substituierte Macrolidantibiotica
US5955440A (en) * 1998-03-27 1999-09-21 Abbott Laboratories Macrolide LHRH antagonists
US5972898A (en) * 1998-03-27 1999-10-26 Abbott Laboratories 3',3-N-bis-substituted macrolide LHRH antagonists
US6387885B1 (en) * 1998-08-26 2002-05-14 Abbott Laboratories 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
US6020521A (en) * 1998-08-26 2000-02-01 Abbott Laboratories Macrolide LHRH antagonists
ATE340183T1 (de) 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
CN1351608A (zh) * 1999-05-24 2002-05-29 辉瑞产品公司 13－甲基红霉素衍生物
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
EP3589327A4 (de) * 2017-03-03 2022-04-06 Synovo GmbH Neuartige antiinfektions- und entzündungshemmungsverbindungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2782793B2 (ja) * 1988-06-15 1998-08-06 大正製薬株式会社 エリスロマイシンａ誘導体およびその製造方法
US5756473A (en) * 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making

Also Published As

Publication number Publication date
WO1997042206A1 (en) 1997-11-13
CA2253330C (en) 2006-07-25
ATE310010T1 (de) 2005-12-15
DE69734678T2 (de) 2006-08-17
IL126625A0 (en) 1999-08-17
ES2252784T3 (es) 2006-05-16
CA2253330A1 (en) 1997-11-13
AU726075B2 (en) 2000-10-26
DE69734678D1 (de) 2005-12-22
EP1007530B1 (de) 2005-11-16
BR9708929A (pt) 1999-08-03
AU2998797A (en) 1997-11-26
EP1007530A1 (de) 2000-06-14
NZ332320A (en) 2000-07-28
CZ351898A3 (cs) 1999-04-14

Similar Documents

Publication Publication Date Title
CA2253338A1 (en) 6-o-substituted erythromycins and method for making them
TR199901127T2 (xx) Antibakteriyel etkili 6-O-ikameli ketolitler.
YU11699A (sh) 6-supstituisani ketolidi koji imaju antibakterijsko dejstvo, postupci za njihovo dobijanje i njihovi farmaceutski preparati
WO2003004509A3 (en) C12 modified erythromycin macrolides and ketolides having antibacterial activity
WO2000044761A3 (en) Ketolide antibiotics
WO2004062601A3 (en) Antibacterial agents
EA199901016A1 (ru) 9-оксим-производные эритромицина
WO2000026224A3 (en) Novel macrolide antibiotics
PT876388E (pt) Derivados de eritromicina triciclica
DE60039238D1 (de) C-2-modifizierte erythromycinderivate
DK1007530T3 (da) 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf
WO2004096823A3 (en) Novel ketolide derivatives
MX9708611A (es) Compuestos de dialquiltiacumicina.
ES2191778T3 (es) Derivados de 3-desoxi-3-descladinosa de las eritromicinas a y b.
CA2564020A1 (en) 6-o-substituted ketolides having antibacterial activity
BG103985A (en) Multicyclic derivatives of erythromycin
ATE254625T1 (de) Eythromycinderivat mit antibiotischer aktvität